Worth reading
65In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Improvement
Direction inferred from the company’s description.Scale
400
¥ millions (increase in consolidated net sales)Wording
Avoiding a definitive answer
How definitive the wording is.Items stated in the management plan
Partially revisedNet Sales+6.5%
基準 6,200Target6,600million yen
Operating profit+22.1%
基準 1,040Target1,270million yen
ROE+1.0pt
基準 26Target27%
Each line is the climb from the baseline the document states to the target it sets. The slope is scaled against the largest climb in this document. For metrics expressed as percentages, differences are shown in percentage points (pt).The increase shown by the dotted line is calculated from the two reported figures because the company did not provide the amount of growth.
Net income for the current fiscal yearNot disclosed → 890 million yen
Only the target level is shown because the current level for comparison was not provided.What happened to the previous planRevised plan announced in November 2025 (FY3/26): consolidated net sales of ¥6,100 million and operating profit of ¥1,040 million → FY3/26 actual: consolidated net sales of ¥6,192 million and operating profit of ¥1,150 million+1.5%Calculated from the two disclosed figures
Key initiatives
01Geographic expansion
02Strengthening the medical care system
03Pooling the capabilities of the Group
04Digital transformation (DX) and data utilization
Plan assumptionsEarnings forecasts are prepared conservatively, taking into account uncertainties including the situation in the Middle East, The impact of extended construction periods and higher construction costs resulting from tight supply and demand in the construction industry, Growing demand for advanced medical care and persistently excess demand
Segment targetName Kawasaki Hospital / Sales Target 2,170 million yen / Profit Target Not disclosed, Name Tokyo Hospital / Sales Target 1,080 million yen / Profit Target Not disclosed, Name Nagoya Hospital / Sales Target 660 million yen / Profit Target Not disclosed, Name Osaka Hospital / Sales Target 990 million yen / Profit Target Not disclosed
Non-financial targetsIndicator name Number of initial consultations / Target value 11,604 cases / Timing FY3/27, Indicator name Number of veterinarians providing secondary care / Target value 120 people / Timing FY3/27
Size of the Target MarketPet insurance market: ¥152.0 billion in 2025, ¥165.0 billion in 2026 (estimate), ¥178.0 billion in 2027 (forecast), and ¥189.0 billion in 2028 (forecast). Sources: Fuji Keizai, "Comprehensive Marketing Survey of the Pet-Related Market"; Pet Food Association, "National Survey of Dog and Cat Ownership", Total pet-related market: ¥1.9257 trillion in 2025, ¥1.9749 trillion in 2026, and ¥2.0279 trillion in 2027. Sources: Yano Research Institute, "Comprehensive Pet Business Marketing Survey 2025 Edition"; Ministry of Internal Affairs and Communications, "Family Income and Expenditure Survey"
Risks identified by the company
Potential difficulties in procuring components, manufacturing delays, and shortages of existing rental inventory due to the impact of the situation in the Middle East
Potential postponement of the release schedule for next-generation products due to the impact of the situation in the Middle East
Extended construction periods due to tight supply and demand in the construction industry
Higher construction costs
Extension of the construction period for the MRI replacement at Kawasaki Main Hospital
Reason for revision or withdrawal
The policy was changed to strengthen strategic investment in order to accelerate growth. Targets were achieved in almost all areas during the first and second years.
| Item | Details |
|---|---|
| Plan name | Medium-term plan (FY3/25–FY3/27) |
| Plan period | FY3/25–FY3/27 |
| Progress against the plan | Partially revised |
| Sales Target | 6,200 million yen → 6,600 million yen |
| Operating profit target | 1,040 million yen → 1,270 million yen |
| Net income target | Not disclosed → 890 million yen |
| ROE target | At least 14% (previous plan target) / 18.5% (FY3/26 actual) → 17.0% (FY3/27 target) |
| Segment target | Name Kawasaki Hospital / Sales Target 2,170 million yen / Profit Target Not disclosed, Name Tokyo Hospital / Sales Target 1,080 million yen / Profit Target Not disclosed, Name Nagoya Hospital / Sales Target 660 million yen / Profit Target Not disclosed, Name Osaka Hospital / Sales Target 990 million yen / Profit Target Not disclosed |
| Non-financial targets | Indicator name Number of initial consultations / Target value 11,604 cases / Timing FY3/27, Indicator name Number of veterinarians providing secondary care / Target value 120 people / Timing FY3/27 |
| Plan assumptions | Earnings forecasts are prepared conservatively, taking into account uncertainties including the situation in the Middle East, The impact of extended construction periods and higher construction costs resulting from tight supply and demand in the construction industry, Growing demand for advanced medical care and persistently excess demand |
| Key initiatives | Geographic expansion, Strengthening the medical care system, Pooling the capabilities of the Group, Digital transformation (DX) and data utilization |
| Results under the previous plan | Revised plan announced in November 2025 (FY3/26): consolidated net sales of ¥6,100 million and operating profit of ¥1,040 million → FY3/26 actual: consolidated net sales of ¥6,192 million and operating profit of ¥1,150 million |
| Reason for revision or withdrawal | The policy was changed to strengthen strategic investment in order to accelerate growth. Targets were achieved in almost all areas during the first and second years. |
| Size of the Target Market | Pet insurance market: ¥152.0 billion in 2025, ¥165.0 billion in 2026 (estimate), ¥178.0 billion in 2027 (forecast), and ¥189.0 billion in 2028 (forecast). Sources: Fuji Keizai, "Comprehensive Marketing Survey of the Pet-Related Market"; Pet Food Association, "National Survey of Dog and Cat Ownership", Total pet-related market: ¥1.9257 trillion in 2025, ¥1.9749 trillion in 2026, and ¥2.0279 trillion in 2027. Sources: Yano Research Institute, "Comprehensive Pet Business Marketing Survey 2025 Edition"; Ministry of Internal Affairs and Communications, "Family Income and Expenditure Survey" |
| Risks identified | Potential difficulties in procuring components, manufacturing delays, and shortages of existing rental inventory due to the impact of the situation in the Middle East, Potential postponement of the release schedule for next-generation products due to the impact of the situation in the Middle East, Extended construction periods due to tight supply and demand in the construction industry, Higher construction costs, Extension of the construction period for the MRI replacement at Kawasaki Main Hospital |
| Publication date | 22 June 2026 |
Items this document does not state (9)
Operating profit margin targetROIC targetPayout ratio / DOE policyTreasury share acquisition policyCost of capitalSelf-assessment of PBR and share priceTotal investment planInvestment amount by sectorDate of board resolution
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The Company explains that it achieved its targets in almost all areas during the first and second years and expects to continue growing steadily. It has also changed its policy to strengthen strategic investment in order to accelerate growth. At the same time, it has prepared its earnings forecasts conservatively, taking into account uncertainties including the situation in the Middle East.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.